Enovis Corporation to Participate in Investor Conferences in August and September.
PorAinvest
viernes, 8 de agosto de 2025, 9:03 am ET1 min de lectura
ENOV--
Enovis Corporation is dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The company's extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. Enovis' shares of common stock are listed on the New York Stock Exchange under the symbol ENOV.
The Canaccord Genuity 45th Annual Growth Conference is scheduled for August 13th at 8:30 a.m. ET, the Wells Fargo Healthcare Conference is set for September 3rd at 2:15 p.m. ET, and the Baird 2025 Global Healthcare Conference will take place on September 10th at 3:10 p.m. ET. Live audio webcasts and replays of these events will be accessible through the Investors section of the company's website under Events and Presentations.
References:
1. [1] https://ir.enovis.com/stock-information/historic-stock-lookup
2. [2] https://www.stocktitan.net/news/ENOV/enovis-to-participate-in-upcoming-investor-1y2zg1jfdxp4.html
3. [3] https://www.globenewswire.com/news-release/2025/08/08/3130159/0/en/Enovis-to-Participate-in-Upcoming-Investor-Conferences.html
4. [4] https://www.marketscreener.com/news/enovis-announces-second-quarter-2025-results-ce7c5edfd881f023
WFC--
Enovis Corporation, a medical technology growth company, announced that its management team will participate in three investor conferences: Canaccord Genuity 45th Annual Growth Conference, Wells Fargo Healthcare Conference, and Baird 2025 Global Healthcare Conference. The events will be webcast live on the company's website. Enovis Corporation is focused on developing clinically differentiated solutions to improve patient outcomes and transform workflows.
Enovis Corporation (NYSE: ENOV), a leading medical technology growth company, has announced its participation in three major investor conferences. The events, which will be webcast live on the company's website, include the Canaccord Genuity 45th Annual Growth Conference, the Wells Fargo Healthcare Conference, and the Baird 2025 Global Healthcare Conference. These conferences will provide investors with an opportunity to engage with Enovis' management team and gain insights into the company's strategic initiatives and financial performance.Enovis Corporation is dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The company's extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. Enovis' shares of common stock are listed on the New York Stock Exchange under the symbol ENOV.
The Canaccord Genuity 45th Annual Growth Conference is scheduled for August 13th at 8:30 a.m. ET, the Wells Fargo Healthcare Conference is set for September 3rd at 2:15 p.m. ET, and the Baird 2025 Global Healthcare Conference will take place on September 10th at 3:10 p.m. ET. Live audio webcasts and replays of these events will be accessible through the Investors section of the company's website under Events and Presentations.
References:
1. [1] https://ir.enovis.com/stock-information/historic-stock-lookup
2. [2] https://www.stocktitan.net/news/ENOV/enovis-to-participate-in-upcoming-investor-1y2zg1jfdxp4.html
3. [3] https://www.globenewswire.com/news-release/2025/08/08/3130159/0/en/Enovis-to-Participate-in-Upcoming-Investor-Conferences.html
4. [4] https://www.marketscreener.com/news/enovis-announces-second-quarter-2025-results-ce7c5edfd881f023
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios